Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
30.3M
-
Shares change
-
-778K
-
Total reported value, excl. options
-
$442M
-
Value change
-
-$10.4M
-
Put/Call ratio
-
0.45
-
Number of buys
-
46
-
Number of sells
-
-49
-
Price
-
$14.55
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q3 2022
129 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q3 2022.
2seventy bio, Inc. - Common Stock (TSVT) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.3M shares
of 52.4M outstanding shares and own 57.91% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.21M shares), VANGUARD GROUP INC (2.36M shares), EcoR1 Capital, LLC (2.34M shares), STATE STREET CORP (2.3M shares), BAKER BROS. ADVISORS LP (2.06M shares), Bain Capital Life Sciences Investors, LLC (1.41M shares), ARMISTICE CAPITAL, LLC (1.26M shares), RTW INVESTMENTS, LP (1.23M shares), Madison Avenue Partners, LP (1.2M shares), and GOLDMAN SACHS GROUP INC (1.06M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.